Position in RLMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,311,957
+$446,646 QoQ
Shares Held
767,624
+9.8% QoQ
Ownership
0.720%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 126 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Derivatives in RLMD
reported options exposure · as of Mar 31, 2026CallValue
$169,128
CallShares
24,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. RLMD ranks #193 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in RLMD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,311,957 | 767,624 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,865,311 | 699,039 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $169,128 | 24,300 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $117,369 | 24,300 | Call | Defined | 2026-03-25 | |
| 2025-12-31 | $700,350 | 145,000 | Shares | Defined | 2026-03-25 | |
| 2025-03-31 | $32,630 | 120,852 | Shares | Defined | 2025-06-27 | |
| 2024-03-31 | $549,829 | 118,243 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $38,994 | 12,998 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $399,373 | 162,347 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $451,601 | 199,824 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $913,363 | 261,709 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $2,641,265 | 71,347 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $3,497,464 | 184,174 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $790,563 | 29,291 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,899,008 | 84,288 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $2,256,208 | 86,082 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $238,314 | 7,445 | Shares | Defined | 2021-08-13 | |
| 2021-06-30 | $403,326 | 12,600 | Call | Defined | 2021-08-13 | |
| 2021-03-31 | $376,183 | 10,684 | Shares | Defined | 2021-05-17 | |
| 2021-03-31 | $443,646 | 12,600 | Call | Defined | 2021-05-17 | |
| 2020-12-31 | $451,705 | 14,085 | Shares | Defined | 2021-02-12 | |
| 2020-03-31 | $3,624,016 | 106,245 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||